An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)

Clinical trial NCT01483898 · COMPLETED

Trial details

NCT number: NCT01483898
Sponsor: Vericel Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Critical Limb Ischemia

Start date: 2012-02-01
Primary completion: 2014-03-25
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.